RecruitingNCT04998227
Latent TGF-β-binding Proteins Affect the Fibrotic Process in Renal Impairment and Cardiac Dysfunction
Sponsor
National Taiwan University Hospital
Enrollment
300 participants
Start Date
Apr 26, 2021
Study Type
OBSERVATIONAL
Conditions
Summary
The project is planed to explore the impact of LTBP4 and other matrix protein and potentially related biomarkers on renal outcomes, cardiac outcomes and all-cause mortality in patients with suspected acute coronary syndrome (ACS).
Eligibility
Min Age: 20 YearsMax Age: 80 Years
Inclusion Criteria1
- \- acute coronary syndrome patients
Exclusion Criteria1
- \- cardiogenic shock, pregnancy, end-stage renal disease
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04998227
Related Trials
Florbetaben for Imaging of Vascular Amyloid
NCT060913191 location
Evaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Patients With Acute Coronary Syndromes
NCT0710262858 locations
Artificial Intelligence-Driven Medipixel Fractional Flow Reserve Versus Invasive Fractional Flow Reserve-Guided PCI Trial (AIM-FFR Trial)
NCT0732969923 locations
Positive Emotions Following Acute Cardiac Events
NCT054128621 location
A Study Evaluating the Vascular Healing and Neointimal Transformation at 1 Month After Implantation of BioFreedom™ Drug-coated Stents and the Xience Drug-eluting Stent System in Patients With Acute Coronary Syndrome and High Bleeding Risk Using Optical Coherence Tomography
NCT072308471 location